Skip to content

Evaluation of Valvular Heart Disease Using Cardiac CT

Evaluation of Valvular Heart Disease: Multicenter Registry of Noninvasive Imaging Modalities by Cardiac CT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06937125
Enrollment
350
Registered
2025-04-22
Start date
2025-03-12
Completion date
2028-03-31
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular Heart Disease

Brief summary

The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis. 1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.

Interventions

None listed

Sponsors

Toho University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows * 18 years of age or older

Exclusion criteria

* Less than 18 years old * Acute VHD * Infectious endocarditis * Patients with post-VHD intervention * Poor CT image quality for analyzing CT data.

Design outcomes

Primary

MeasureTime frame
the 1-year composite endpoint of all-cause death and major cardiac adverse events (MACE) including VHD intervention.one year

Countries

Japan

Contacts

Primary ContactHideki Koike, MD, PhD
hideki.koike@med.toho-u.ac.jp81+3-3762-4151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026